Hallucinogenic Drugs: A New Study Answers Old Questions about LSD
- 1 February 2017
- journal article
- editorial
- Published by Elsevier in Current Biology
- Vol. 27 (4) , R156-R158
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Acute Effects of Lysergic Acid Diethylamide in Healthy SubjectsBiological Psychiatry, 2015
- Recent advances in the neuropsychopharmacology of serotonergic hallucinogensBehavioural Brain Research, 2015
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening DiseasesJournal of Nervous & Mental Disease, 2014
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage CancerArchives of General Psychiatry, 2011
- Serotonin research: contributions to understanding psychosesTrends in Pharmacological Sciences, 2008
- Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in SchizophreniaAmerican Journal of Psychiatry, 2003
- LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsPsychopharmacology, 1995
- Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)Psychopharmacology, 1987
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agentsLife Sciences, 1984
- A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERSProceedings of the National Academy of Sciences, 1954